State Initiative Pushes Electronic Prescribing
Health organizations throughout Maryland recently formed the Maryland Safety Through Electronic Prescribing (STEP) Initiative. Its main goal is to fast-forward the voluntary adoption of electronic prescribing among physician practices in Maryland to improve patient safety. The 27 organizations comprising the Maryland STEP Initiative want to provide a collaborative forum for leading stakeholders to address the obstacles to implementation and the barriers to adoption.
The participants believe that patients, physician practices, pharmacies, and payers will benefit from widespread adoption of electronic prescribing. The organizations emphasize that patient safety will be improved through reduced errors caused by misinterpreted handwriting and verbal communications, unclear abbreviations or dose designations, and fax problems.
"Electronic prescribing has important patient safety and practice efficiency benefits and should be implemented with a migration or integration path towards use of a full electronic health record," said Michael Tooke, MD, chief medical officer of Delmarva Foundation. "Some physicians are not ready for a full electronic health record, and, for them, electronic prescribing can be a very good step in the right direction."
The Maryland STEP Initiative recognizes that electronic prescribing will streamline communications between pharmacies and physician practices. The steps will result in a reduced number of calls and faxes to clarify prescription information, authorize prescription renewals, and check formulary and benefits eligibility.
Articles in this issue
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Related Articles
Advise Patients About Self-Care Measures to Treat Mild to Moderate GI IssuesSeptember 18th 2025
Evaluation of Pharmacist-Driven Penicillin Allergy ReconciliationSeptember 17th 2025
Pharmacists Can Apply Their Expertise to the Medical Psilocybin ActSeptember 16th 2025
From Curiosity to Clinical Impact: Shremo Msdi’s Path in Pharmacy ResearchSeptember 15th 2025
